Anti-PLA2R Antibodies in Chinese Patients with Membranous Nephropathy
- PMID: 27179439
- PMCID: PMC4913829
- DOI: 10.12659/msm.896090
Anti-PLA2R Antibodies in Chinese Patients with Membranous Nephropathy
Abstract
BACKROUND ~This study used two standardized methods to evaluate anti-PLA2R antibody in serum of primary membranous nephropathy (PMN) among Chinese patients to determine Anti-PLA2R antibody distribution and whether immunological reactivity reflected by antibody titer correlates with kidney function parameters. MATERIAL AND METHOD ~Overall, 82 subjects with biopsy-proven primary membranous nephropathy (PMN) , 22 cases with secondary membranous nephropathy (SMN), 40 non-MN patients with established glomerulonephritis, 20 healthy volunteers were recruited from the Division of Nephrology, Nanfang Hospital, China. Anti-PLA2R antibody in the serum of each patient was evaluated by both recombinant cell-based indirect immunofluorescence assay (RC-IFA) and enzyme linked immunosorbent assay (ELISA). Kidney function was assessed by proteinuria for 24 hours, serum albumin, blood urea nitrogen (BUN), serum creatine, serum cystatin C. We assessed the correlation between anti-PLA2R antibody levels and clinical parameter in the PMN patients. RESULTS ~ Fifty-three patients with PMN (64.6%) were positive for anti-PLA2R antibody. The level of antibody determined by RC-IFA ranged from 1:10 to 1:1000 and 0 to 1423 RU/ml by ELISA. The two anti-PLA2R test systems correlated very well with each other and reached an agreement of 95.7% for PMN patients. The level of antibody detected by ELISA in patients with PMN also significantly correlated with proteinuria and nephritic-range proteinuria (> 3.5g/day) . CONCLUSIONS ~Anti-PLA2R antibody is sensitive and extremely specific for diagnosis of Chinese patients with primary membranous nephropathy. Concentration of autoantibody against PLA2R is an ideal marker for monitoring the activity of immunological disease.
Figures


Similar articles
-
Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years.PLoS One. 2017 Mar 3;12(3):e0173201. doi: 10.1371/journal.pone.0173201. eCollection 2017. PLoS One. 2017. PMID: 28257452 Free PMC article.
-
PLA2R antibodies, glomerular PLA2R deposits and variations in PLA2R1 and HLA-DQA1 genes in primary membranous nephropathy in South Asians.Nephrol Dial Transplant. 2016 Sep;31(9):1486-93. doi: 10.1093/ndt/gfv399. Epub 2015 Dec 15. Nephrol Dial Transplant. 2016. PMID: 26673907
-
Anti-Phospholipase A2 Receptor (Anti-PLA2R) Antibody in Diagnosis and Treatment of Idiopathic Membranous Nephropathy: A Single-Center Observational Study in China.Med Sci Monit. 2019 Dec 9;25:9364-9368. doi: 10.12659/MSM.917732. Med Sci Monit. 2019. PMID: 31813930 Free PMC article.
-
Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN).Autoimmun Rev. 2016 Feb;15(2):146-54. doi: 10.1016/j.autrev.2015.10.004. Epub 2015 Oct 23. Autoimmun Rev. 2016. PMID: 26527329 Review.
-
Primary Membranous Nephropathy.Clin J Am Soc Nephrol. 2017 Jun 7;12(6):983-997. doi: 10.2215/CJN.11761116. Epub 2017 May 26. Clin J Am Soc Nephrol. 2017. PMID: 28550082 Free PMC article. Review.
Cited by
-
Novel Biomarkers in Membranous Nephropathy.Front Immunol. 2022 Apr 22;13:845767. doi: 10.3389/fimmu.2022.845767. eCollection 2022. Front Immunol. 2022. PMID: 35529848 Free PMC article. Review.
-
Phospholipase-A2 receptor antibody, 24 hours proteinuria, and serum albumin as indicators of cyclophosphamide efficacy in idiopathic membranous nephropathy.J Clin Lab Anal. 2020 Sep;34(9):e23368. doi: 10.1002/jcla.23368. Epub 2020 May 24. J Clin Lab Anal. 2020. PMID: 32449206 Free PMC article.
-
Rapid, quantitative, and high-sensitivity detection of anti-phospholipase A2 receptor antibodies using a novel CdSe/ZnS-based fluorescence immunosorbent assay.Sci Rep. 2021 Apr 22;11(1):8778. doi: 10.1038/s41598-021-88343-z. Sci Rep. 2021. PMID: 33888834 Free PMC article.
-
Anti-phospholipase A2 receptor antibody as a prognostic marker in patients with primary membranous nephropathy.Kidney Res Clin Pract. 2018 Sep;37(3):248-256. doi: 10.23876/j.krcp.2018.37.3.248. Epub 2018 Sep 30. Kidney Res Clin Pract. 2018. PMID: 30254849 Free PMC article.
-
Analysis of a Screening System for Diabetic Cardiovascular Autonomic Neuropathy in China.Med Sci Monit. 2017 Nov 10;23:5354-5362. doi: 10.12659/msm.905240. Med Sci Monit. 2017. PMID: 29125834 Free PMC article.
References
-
- Kerjaschki D. Pathomechanisms and molecular basis of membranous glomerulopathy. Lancet. 2004;364(9441):1194–96. - PubMed
-
- Stanescu HC, Arcos-Burgos M, Medlar A, et al. Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med. 2011;364(7):616–26. - PubMed
-
- Hu SL, Wang D, Gou WJ, et al. Diagnostic value of phospholipase A2 receptor in idiopathic membranous nephropathy: a systematic review and meta-analysis. J Nephrol. 2014;27(2):111–16. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources